SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's trades in green on the BSE

18 Nov 2011 Evaluate

Dr Reddy's is currently trading at Rs. 1558.00, up by 7.85 points or 0.51% from its previous closing of Rs. 1550.15 on the BSE.

The scrip opened at Rs. 1540.00 and has touched a high and low of Rs. 1578.45 and Rs. 1540.00 respectively. So far 12979 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1855.00 on 09-Dec-2010 and a 52 week low of Rs. 1387.00 on 22-Aug-2011.

Last one week high and low of the scrip stood at Rs. 1654.80 and Rs. 1540.50 respectively. The current market cap of the company is Rs. 26281.87 crore.

The promoters holding in the company stood at 25.61% while Institutions and Non-Institutions held 40.74% and 15.99% respectively.

Dr Reddy's Laboratories’ Andhra Pradesh Srikakulam unit’s production is adversely affected for the past 3-4 days due to workers strike. The workers in all 13 production blocks have participated in protest resulting in nil production at the unit. The production is made based out of orders and hence company is unable to estimate exact loss.

Presently, active pharmaceutical ingredients making unit has about 700 employees on its rolls besides about 300-350 contract workers. The number of contract workers was scaled down to about 85 following which the protests started. 

Dr. Reddy's Laboratories is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1315.85 -17.20 (-1.29%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×